彭順國際(06163.HK):彭慧嫻辭任執行董事及集團首席行政官等職務
格隆匯 12 月 8日丨彭順國際(06163.HK)宣佈,自2020年12月8日起,彭慧嫻已辭任執行董事、集團首席行政官及公司若干附屬公司的董事,以投放更多時間於其他私人事務上。彭慧嫻於辭任後亦自2020年12月8日起終止出任根據聯交所上市規則第3.05條所規定的公司授權代表("授權代表")。
另宣佈,執行董事彭中庸先生已自2020年12月8日起按上市規則第3.05條所規定獲委任為授權代表。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.